MYL7 Polyclonal Antibody

MYL7, also known as myosin light chain 2a (MLC2a), is essential for heart development. The expression of MYL7 in heart is predominatantly restricted to the atrium. So its expression has been considered as useful marker for atrial cardiomyocytes.

The MYL7 Polyclonal Antibody is a highly specific and reliable tool for the detection and analysis of MYL7 protein expression. This antibody has been extensively validated for use in various applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The MYL7 Polyclonal Antibody exhibits exceptional sensitivity and specificity, ensuring accurate and reproducible results. It recognizes endogenous levels of MYL7 protein in a wide range of species, making it suitable for use in diverse research settings.

With its superior performance characteristics, the MYL7 Polyclonal Antibody is an invaluable tool for investigating the role of MYL7 in various biological processes. Its high affinity and selectivity enable precise detection and quantification of MYL7 protein levels, facilitating a deeper understanding of its function and involvement in cellular pathways.

Furthermore, the MYL7 Polyclonal Antibody is manufactured using state-of-the-art techniques and undergoes rigorous quality control measures to ensure batch-to-batch consistency and reliability. It is supplied in a convenient and ready-to-use format, allowing for seamless integration into experimental workflows.

In summary, the MYL7 Polyclonal Antibody is a top-tier research reagent that offers exceptional performance, reliability, and versatility. Its application in various techniques and its ability to accurately detect and quantify MYL7 protein make it an indispensable tool for scientists and researchers in the field.